News Release

<< Back

  View printer-friendly version

Teleflex Publishes Inaugural Corporate Social Responsibility (CSR) Report

The report highlights how employees are driving the company mission into their communities, what the company and employees are doing to help protect the environment and how the company is achieving high standards for business progress

WAYNE, Pa., March 26, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced the publication of its inaugural corporate social responsibility report, The JOIN Impact Report. The report outlines the company’s responsibility commitments and activities in the areas of people, the environment and business progress.

“Our employees truly make the greatest impact,” said Liam Kelly, President and CEO. “We have something special happening at Teleflex beyond our clinically proven medical device products and related services. Our employees’ commitment is evident in what they do for their communities, the environment and humanitarian aid. Their engagement in CSR is demonstrating how we are making a difference in the health and quality of people’s lives.”

Teleflex celebrated its 75th Anniversary in 2018.  To commemorate this milestone, approximately 4,000 employees at 50 Teleflex sites across the globe gave back to 76 charities.

Cam Hicks, Vice President of Global Human Resources and Employee Communications shared, “Because of our employees, Teleflex has an outstanding culture and we credit them for bringing our Core Values to life every day.”

The JOIN Impact Report, along with related policies, statements and program information, can be accessed through the investor page of the company’s website, or directly at www.teleflex.com/csr.

About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rüsch®, UroLift®, and Weck® – trusted brands united by a common sense of purpose.

Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

Teleflex, the Teleflex logo, Arrow, Deknatel, Hudson RCI, LMA, Pilling, Rüsch, UroLift, and Weck are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries.
© 2019 Teleflex Incorporated. All rights reserved.

Source:
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice President, Investor Relations
610-948-2836

TeleflexLogo.jpg

Source: Teleflex Incorporated